Home
½ÃÀÛÆäÀÌÁö
Áö³È£º¸±â
·Î±×ÀÎ
ȸ¿ø°¡ÀÔ
±¸µ¶½Åû
Àüü±â»ç
2024-03-29 ±Ý 22:03
±â»ç°Ë»ö
Cover Story
¼øȯ±â
³»ºÐºñ
È£Èí±â
¼Òȱâ
½Å°æ°ú
Á¤½Å°Ç°
°¨¿°³»°ú
Sub Story
Interview
Drug Review
Conference Report
Late Breaking Studies
Expert Opinion
Primary Expert Opinion
The Rare Disease
ÇмúÀÚ¹®À§¿ø
RTM
»ó´Ü¿©¹é
񃯇
(Àüü 924°Ç)
Á¦¸ñº¸±â
Á¦¸ñº¸±â
Á¦¸ñ+³»¿ë
[Sub Story]
½ÉÇ÷°üÁúȯ ¿¹¹æ Ç×Ç÷¼ÒÆÇ¿ä¹ýÀÇ ÇöÀç
ÀÌ»óµ· ±âÀÚ
2016-06-08 09:36
[Sub Story]
Ú¸ ½ÉÀåÇаè DAPT ±â°£ °¡ÀÌµå ¹ßÇ¥
ÀÌ»óµ· ±âÀÚ
2016-06-08 09:24
[Sub Story]
½Ç·Î½ºÅ¸Á¹ÀÇ ³úÁ¹Áß ¿¹¹æÈ¿°ú
ÀÌ»óµ· ±âÀÚ
2016-06-08 09:08
[Late Breaking Studies]
ÀÌÇÁ¶ó±Û¸®Ç÷ÎÁø ºñ¾ËÄڿüº Áö¹æ°£Áúȯ ÁöÇ¥ °³¼±
ÀÌ»óµ· ±âÀÚ
2016-05-18 11:24
[Interview]
½É´ë¿¬, ´ë±¹¹Î ¸Þ½ÃÁö µé°í Àü±¹ Ä·ÆäÀÎ ÆîÄ£´Ù
ÀÌ»óµ· ±âÀÚ
2016-05-18 11:13
¶óÀÎ
[Interview]
¡°´ë»çÁõÈıº ¿¹¹æ¡¤Ä¡·á »ýÈ°½À°ü ±³Á¤ÀÌ Çٽɡ±
ÀÌ»óµ· ±âÀÚ
2016-05-18 11:11
[Cover Story]
½ÉÀå´ë»çÁõÈıº¿¬±¸È¸ ½ÉÇ÷°üÁúȯ ¿¹¹æ¿¡ µÎ ÆÈ °È´Ù
ÀÌ»óµ· ±âÀÚ
2016-05-18 10:56
[Sub Story]
½ºÅ¸Æ¾ + ¿¡Á¦Æ¼¹Ìºê Àü·« Pleiotropic Effect of Ezetimibe
ÀÌ»óµ· ±âÀÚ
2016-05-17 20:44
[Sub Story]
ÀÜ¿© ½ÉÇ÷°ü À§Çè°ú °íÁß¼ºÁö¹æÇ÷Áõ ¹× ÀúHDLÄÝ·¹½ºÅ×·ÑÇ÷Áõ
ÀÌ»óµ· ±âÀÚ
2016-05-17 18:20
[Sub Story]
´ë»çÁõÈıº ȯÀÚ ½ÉÇ÷°üÁúȯ À§Çè
ÀÌ»óµ· ±âÀÚ
2016-05-09 19:16
¶óÀÎ
[Sub Story]
´ë»çÁõÈıº, Ç÷¾Ð¡¤Ç÷´ç¡¤ÁöÁú Á¾ÇÕÄ¡·á
ÀÌ»óµ· ±âÀÚ
2016-05-09 18:21
[Sub Story]
´ë»çÁõÈıº Æú¸®ÇÊ Àü·«
ÀÌ»óµ· ±âÀÚ
2016-05-09 18:16
[Late Breaking Studies]
»ì¸ÞÅ×·Ñ º´¿ë¿ä¹ý ¾ÈÀü¼º È®ÀÎ
ÀÌ»óµ· ±âÀÚ
2016-04-28 16:23
[Sub Story]
´ëÇѹα¹ õ½Ä°ü¸® ½ÇÅ ±¸¸Û³ õ½ÄȯÀÚ °ü¸®
ÀÌ»óµ· ±âÀÚ
2016-04-28 15:43
[Sub Story]
õ½ÄÄ¡·á 4¡¤5´Ü°è¿¡ Ƽ¿ÀÆ®·ÎÇÇ¿ò ±Ç°í
ÀÌ»óµ· ±âÀÚ
2016-04-28 15:24
¶óÀÎ
[Sub Story]
The More, The Lower, The Better
ÀÌ»óµ· ±âÀÚ
2016-04-12 16:41
[Sub Story]
SPRINT, 120mmHg ¹Ì¸¸ Á¶Àý½Ã ½ÉÇ÷°ü»ç°Ç¡¤»ç¸Á·ü¡é
ÀÌ»óµ· ±âÀÚ
2016-04-12 16:35
[Sub Story]
Ç×°íÇ÷¾ÐÁ¦ º´¿ë¿ä¹ý ¾ç¡¤Áú ¸ðµÎ¿¡¼ ÇýÅÃ
ÀÌ»óµ· ±âÀÚ
2016-04-12 16:30
[Sub Story]
Evidence Says ¡°the more, the lower, the better¡±
ÀÌ»óµ· ±âÀÚ
2016-04-12 16:16
[Sub Story]
Combination Therapy - Dyslipidemia
ÀÌ»óµ· ±âÀÚ
2016-04-12 16:07
-
ÀÌÀü
41
42
43
44
45
46
47
-
¿©¹é
Sub
news
¡°ACEI ÀÓ»ó±Ù°Å ³õ°í, ȯÀÚ ¼³µæÇÏÀÚ¡±
Q. Ç÷¾Ð°ÇÏ Ãø¸é¿¡¼ ACEIÀÇ Æ¯¼ºÀº?ù...
¡°SGLT-2i Ȳ±Ý±â´Â TZD¿Í º´¿ëÀ¸·ÎºÎÅÍ¡±
Q. SGLT-2iÀÇ °è¿È¿°ú¿¡ ´ëÇÑ °ßÇØ´Â...
¡°°í°µµ ½ºÅ¸Æ¾ Á¦Á¦ È¿°ú ´ëµîÇϳª ¾ÈÀü¼º ´Ù¸¦ ¼öµµ¡±
Q. CAD ȯÀÚÀÇ ÀÌ»óÁöÁúÇ÷Áõ Ä¡·áÀü·«Àº?...
¿©¹é
¿©¹é
Back to Top